Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange.
Yango
A
A
Morrissey
P
P
Monaco
A
A
Butera
J
J
Gohh
R Y
RY
D003131:Combined Modality Therapy; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation; D008875:Middle Aged; D010951:Plasma Exchange; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced / Q000628:therapy*; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus